COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 25 of 928 for:    Advanced | Neuroendocrine Tumors

Personalized CAPTEM Radiopeptide Therapy of Advanced, Non-resectable Neuroendocrine Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04194125
Recruitment Status : Recruiting
First Posted : December 11, 2019
Last Update Posted : November 4, 2020
Maria Sklodowska-Curie Institute - Oncology Center
The Medical University of Warsaw; Poland
The Diagnostic and Therapeutic Center Gammed; Poland
National Center for Research and Development, Poland
Information provided by (Responsible Party):
Jaroslaw B. Cwikla, MD, PhD, Professor UWM, University of Warmia and Mazury

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 30, 2021
Estimated Study Completion Date : January 31, 2022